SYREON RESEARCH INSTITUTE WAS REPRESENTED IN THE ISPOR 21TH ANNUAL EUROPEAN CONGRESS IN BARCELONA

Syreon Research Institute presents 17 posters, 2 workshops and 1 short course at the ISPOR 21th Annual European Congress in Barcelona:

POSTERS:

• BEHIND THE SUBCUTANEOUS TRASTUZUMAB HYPE: EVALUATION OF BENEFITS AND THEIR TRANSFERABILITY TO CENTRAL EASTERN EUROPEAN COUNTRIES (Inotai A, Zemplényi A, Karpenko A, Agh T,  Kalo Z)

• COMPARISON OF THE HEALTH TECHNOLOGY ASSESSMENT OFFICES OF HUNGARY AND POLAND BASED ON OBJECTIVE CRITERIA (Nemeth B, Krupa D, Staniak A, Jozwiak-Hagymasy J, Voko Z)

• COST-UTILITY ANALYSIS OF CARIPRAZINE COMPARED TO RISPERIDONE AMONG PATIENTS WITH NEGATIVE SYMPTOMS OF SCHIZOPHRENIA IN SELECTED CENTRAL AND EASTERN EUROPEAN COUNTRIES (Nemeth B, Bendes R, Nagy B, Deak IA, Toth B, Koczian K, Horvath M, Croitoru C, Tarhajova M, Psota M, Kuchar J, Bucek Psenkova M, Voko Z)

• COST-UTILITY ANALYSIS OF CARIPRAZINE COMPARED TO RISPERIDONE AMONG PATIENTS WITH NEGATIVE SYMPTOMS OF SCHIZOPHRENIA IN SELECTED NORDIC COUNTRIES (Nemeth B, Bendes R, Nagy B, Corcoran K, Lelli F, Fonticoli L, Voko Z)

• CLINICAL RESPONSE TO SYSTEMIC TREATMENTS FOR STEROID-REFRACTORY CHRONIC GRAFT-VERSUS-HOST DISEASE: A SYSTEMATIC LITERATURE REVIEW (Agh T, Csanadi M, Elezbawy B, Webb T, Mahler M, Sengupta N, Voko Z)

• ASSESSING THE HEALTH AND ECONOMIC IMPACT OF PHARMACEUTICAL CARE IN ELDERLY PATIENTS WITH DIABETES: A SYSTEMATIC LITERATURE REVIEW (Obeng GD, Inotai A, Hanko B, Agh T, Csanadi M) 

• HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH CHRONIC GRAFT VERSUS HOST DISEASE: A SYSTEMATIC LITERATURE REVIEW (Agh T, Elezbawy B, Loek Akker L, Webb T, Jeyakumaran D, Mahler M, Sengupta N Trudeau J , Csanadi M)

• ROADMAP FOR IMPLEMENTATION OF HEALTH TECHNOLOGY ASSESSMENT IN ROMANIA (Rais C,  Kalo Z , Csanadi M, Negulescu V)

• HEALTH TECHNOLOGY ASSESSMENT ROADMAP FOR UKRAINE - THE PERSPECTIVE OF STAKHOLDERS ON CURRENT STATUS AND FUTURE OPPORTUNITIES (Csanadi M, Inotai A, Nemeth B , Oleshchuk O, Lebega O, Alexandra B, Piniazhko O, Kalo Z)

• SYSTEMATIC LITERATURE REVIEW ON THE EPIDEMIOLOGY OF PROPIONIC ACIDEMIA (PA) (Almasi T, Guey TL, Lukacs C, Csetneki K, Voko Z, Zelei T

• CLINICAL BURDEN OF CHRONIC GRAFT VERSUS HOST DISEASE: A SYSTEMATIC LITERATURE REVIEW OF INCIDENCE AND DISEASE SEVERITY (Csanadi M, Elezbawy B, Tordai A, Webb T, Mahler M, Sengupta N, Jeyakumaran D, Agh T)

• OVERALL SURVIVAL AND NON-RELAPSE MORTALITY OF PATIENTS WITH CHRONIC GRAFT-VERSUS-HOST DISEASE: A SYSTEMATIC LITERATURE REVIEW (Agh T, Csanadi M, Elezbawy B, Webb T, Mahler M, Sengupta N, Tordai A)

• ROLE OF SUPPLEMENTARY AND COMPLEMENTARY PRIVATE HEALTH INSURANCE IN SELECTED COUNTRIES (Almasi T, Magd El AE, George M, Arnaiz F, Fasseeh A, Elezbawy B, Abaza S, Nagy B, Kalo Z)

• SYSTEMATIC LITERATURE REVIEW ON THE EPIDEMIOLOGY OF METHYLMALONIC ACIDEMIA (MMA) WITH A FOCUS ON MMA CAUSED BY METHYLMALONYL-COA MUTASE (MUT) DEFICIENCY (Almasi T, Guey TL, Lukacs C, Csetneki K, Voko Z, Zelei T)

• HEPATITIS C VIRUS ELIMINATION AND ERADICATION MODELS:A SYSTEMATIC LITERATURE REVIEW (Laszlo Szilberhorn, Agh T, Kalo Z)

SHORT COURSE:

• RISK-SHARING/PERFORMANCE-BASED ARRANGEMENTS IN CENTRAL & EASTERN EUROPE: IMPLEMENTATION OF MANAGED ENTRY AGREEMENTS (Kalo Z)

WORKSHOPS:

• POLICY MEASURES TO MAXIMISE PATIENT ACCESS AFTER THE INTRODUCTION OF BIOSIMILAR MEDICINES IN THE OFF-PATENT BIOLOGICAL MARKET (Inotai A)

• ECONOMIC MODEL CHOICE, VALIDATION, AND SHARING: PRAGMATIC ROADMAPS FOR PHARMACOECONOMIC PRACTICE (Nagy B, Kalo Z)

More information about the conference: Link